Table 1. Baseline characteristics and clinical outcomes.
Demographic/clinical characteristic | n = 176 |
---|---|
Median age (range) | 55 (13–76) |
Males (%) | 140 (79%) |
IMDC criteria (n, %) | |
Favourable | 36 (20%) |
Intermediate | 109 (62%) |
Poor | 31 (18%) |
Best Response to HDIL-2 | |
CR | 16 (9%) |
PR | 11 (6%) |
Stable disease (SD) | 52 (30%) |
Progressive disease (PD)/Not evaluable (NE) | 97 (58%) |
PFS (median) | 5.6 |
OS (median) | 19.9 |